Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosus

Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosus

Objective To evaluate both humoral and cellular immune responses to the COVID-19 messenger RNA (mRNA; BNT162b2) vaccine in patients with childhood-onset SLE (cSLE) compared with healthy controls and patient controls (kidney transplant (KTx) recipients).Methods This single-centre, cross-sectional and...

Full description

Saved in:
Bibliographic Details
Main Authors: Ozgur Kasapcopur, Nur Canpolat, Sezgin Sahin, Bekir Kocazeybek, Ayşe Ağbaş, Esra Karabag Yilmaz, Aybuke Gunalp, Dogukan Ozbey, Ruveyda Gulmez, Seha Kamil Saygili, Salim Caliskan
Format: Article
Language:English
Published: BMJ Publishing Group 2024-09-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/11/2/e001268.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://lupus.bmj.com/content/11/2/e001268.full

Similar Items